GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

ZEO ScientifiX ZEOX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.90

-0.98%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$5.2m

FY2016FY2025

Net income

−$5.5m

FY2016FY2025

Free cash flow

−$741,000

FY2016FY2025

Shareholders' equity

−$1.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016
Revenue$5.2m$4.6m$4.6m$6.5m$5.6m$3.1m$964,500$569,900$184,900
Operating income−$5.4m−$5.3m−$6.8m−$8.8m−$12.7m−$12.4m−$3.5m−$8.6m−$1.0m
Net income−$5.5m−$4.7m−$7.0m−$8.9m−$12.8m−$12.6m−$3.5m−$9.0m−$1.3m
Diluted earnings per share-0.82-0.74-0.96-1.20-2.25-2.68-0.01-0.08-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016
Total assets$1.5m$1.6m$2.8m$6.2m$1.9m$1.3m$117,000$376,800$69,900
Cash and short-term investments——————$43,000$39,600$26,200
Total liabilities$3.0m$3.3m$4.0m$4.3m$4.6m$2.7m$1.4m$3.9m$853,000
Debt——————$380,000$220,900$100,000
Shareholders' equity−$1.4m−$1.7m−$1.2m$1.9m−$2.7m−$1.4m−$1.3m−$3.6m−$783,100
Shares outstanding7m6m7m7m6m5m272m109m100m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016
Cash from operations−$718,000−$1.4m−$2.2m−$3.2m−$2.7m−$1.8m−$512,000−$881,500−$548,200
Capital spending−$23,000—−$26,000−$824,743−$424,742−$138,694−$4,600−$45,100−$26,300
Free cash flow−$741,000−$1.4m−$2.2m−$4.0m−$3.1m−$2.0m−$516,600−$926,600−$574,500

Latest quarters

By quarter end

Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024
Revenue$2.6m$1.4m$1.7m$1.3m$1.1m$1.1m$1.2m$1.1m
Operating income−$512,000−$878,000−$668,000−$2.1m−$1.4m−$1.3m−$1.4m−$1.2m
Net income−$145,000−$852,000−$815,000−$2.1m−$1.4m−$1.2m−$1.3m−$1.0m
Diluted earnings per share-0.02-0.11-0.12-0.32-0.22-0.20-0.20-0.15
Total assets$3.9m$2.6m$1.5m$1.7m$1.4m$1.6m$1.6m$2.2m
Shareholders' equity$712,000−$383,000−$1.4m−$2.3m−$2.1m−$1.8m−$1.7m−$1.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-7.1%11.2%—
Operating income-15.2%-15.4%—
Net income-14.7%-15.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016
Price to earnings-3.3-4.2-1.1-3.3-2.5-5.0-6.5-0.1-5.7
Price to sales3.54.31.64.65.720.823.22.438.5

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-21%90%-70%-32%-33%1353%1449%498%-92%-45%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 200-to-1 reverse split · 28 Nov 2023
  • 18-for-1 split · 21 Sept 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.